α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse
Yang, N
Schindeler, A
McDonald, MM
Seto, JT
Houweling, PJ
Lek, M
Hogarth, M
Morse, AR
Raftery, JM
Balasuriya, D
MacArthur, DG
Berman, Y
Quinlan, KGR
Eisman, JA
Nguyen, TV
Center, JR
Prince, RL
Wilson, SG
Zhu, K
Little, DG
North, KN
- Publication Type:
- Journal Article
- Citation:
- Bone, 2011, 49 (4), pp. 790 - 798
- Issue Date:
- 2011-10-01
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
![]() | 2013005854OK.pdf | 811.97 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, N | en_US |
dc.contributor.author | Schindeler, A | en_US |
dc.contributor.author | McDonald, MM | en_US |
dc.contributor.author | Seto, JT | en_US |
dc.contributor.author | Houweling, PJ | en_US |
dc.contributor.author | Lek, M | en_US |
dc.contributor.author | Hogarth, M | en_US |
dc.contributor.author | Morse, AR | en_US |
dc.contributor.author | Raftery, JM | en_US |
dc.contributor.author | Balasuriya, D | en_US |
dc.contributor.author | MacArthur, DG | en_US |
dc.contributor.author | Berman, Y | en_US |
dc.contributor.author | Quinlan, KGR | en_US |
dc.contributor.author | Eisman, JA | en_US |
dc.contributor.author |
Nguyen, TV |
en_US |
dc.contributor.author | Center, JR | en_US |
dc.contributor.author | Prince, RL | en_US |
dc.contributor.author | Wilson, SG | en_US |
dc.contributor.author | Zhu, K | en_US |
dc.contributor.author | Little, DG | en_US |
dc.contributor.author | North, KN | en_US |
dc.date.available | 2011-07-07 | en_US |
dc.date.issued | 2011-10-01 | en_US |
dc.identifier.citation | Bone, 2011, 49 (4), pp. 790 - 798 | en_US |
dc.identifier.issn | 8756-3282 | en_US |
dc.identifier.uri | http://hdl.handle.net/10453/28728 | |
dc.description.abstract | Bone mineral density (BMD) is a complex trait that is the single best predictor of the risk of osteoporotic fractures. Candidate gene and genome-wide association studies have identified genetic variations in approximately 30 genetic loci associated with BMD variation in humans. α-Actinin-3 (ACTN3) is highly expressed in fast skeletal muscle fibres. There is a common null-polymorphism R577X in human ACTN3 that results in complete deficiency of the α-actinin-3 protein in approximately 20% of Eurasians. Absence of α-actinin-3 does not cause any disease phenotypes in muscle because of compensation by α-actinin-2. However, α-actinin-3 deficiency has been shown to be detrimental to athletic sprint/power performance. In this report we reveal additional functions for α-actinin-3 in bone. α-Actinin-3 but not α-actinin-2 is expressed in osteoblasts. The Actn3 -/- mouse displays significantly reduced bone mass, with reduced cortical bone volume (-14%) and trabecular number (-61%) seen by microCT. Dynamic histomorphometry indicated this was due to a reduction in bone formation. In a cohort of postmenopausal Australian women, ACTN3 577XX genotype was associated with lower BMD in an additive genetic model, with the R577X genotype contributing 1.1% of the variance in BMD. Microarray analysis of cultured osteoprogenitors from Actn3 -/- mice showed alterations in expression of several genes regulating bone mass and osteoblast/osteoclast activity, including Enpp1, Opg and Wnt7b. Our studies suggest that ACTN3 likely contributes to the regulation of bone mass through alterations in bone turnover. Given the high frequency of R577X in the general population, the potential role of ACTN3 R577X as a factor influencing variations in BMD in elderly humans warrants further study. © 2011 Elsevier Inc. | en_US |
dc.relation.ispartof | Bone | en_US |
dc.relation.isbasedon | 10.1016/j.bone.2011.07.009 | en_US |
dc.subject.classification | Endocrinology & Metabolism | en_US |
dc.subject.mesh | Bone and Bones | en_US |
dc.subject.mesh | Bone Marrow Cells | en_US |
dc.subject.mesh | Stromal Cells | en_US |
dc.subject.mesh | Stem Cells | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Mice, Inbred C57BL | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Bone Resorption | en_US |
dc.subject.mesh | Actinin | en_US |
dc.subject.mesh | Tomography, X-Ray Computed | en_US |
dc.subject.mesh | Absorptiometry, Photon | en_US |
dc.subject.mesh | Organ Size | en_US |
dc.subject.mesh | Analysis of Variance | en_US |
dc.subject.mesh | Cohort Studies | en_US |
dc.subject.mesh | Osteogenesis | en_US |
dc.subject.mesh | Bone Density | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 and over | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Female | en_US |
dc.title | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse | en_US |
dc.type | Journal Article | |
utslib.citation.volume | 4 | en_US |
utslib.citation.volume | 49 | en_US |
utslib.for | 110306 Endocrinology | en_US |
utslib.for | 0903 Biomedical Engineering | en_US |
utslib.for | 06 Biological Sciences | en_US |
utslib.for | 09 Engineering | en_US |
utslib.for | 11 Medical and Health Sciences | en_US |
pubs.embargo.period | Not known | en_US |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
utslib.copyright.status | closed_access | |
pubs.issue | 4 | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 49 | en_US |
Abstract:
Bone mineral density (BMD) is a complex trait that is the single best predictor of the risk of osteoporotic fractures. Candidate gene and genome-wide association studies have identified genetic variations in approximately 30 genetic loci associated with BMD variation in humans. α-Actinin-3 (ACTN3) is highly expressed in fast skeletal muscle fibres. There is a common null-polymorphism R577X in human ACTN3 that results in complete deficiency of the α-actinin-3 protein in approximately 20% of Eurasians. Absence of α-actinin-3 does not cause any disease phenotypes in muscle because of compensation by α-actinin-2. However, α-actinin-3 deficiency has been shown to be detrimental to athletic sprint/power performance. In this report we reveal additional functions for α-actinin-3 in bone. α-Actinin-3 but not α-actinin-2 is expressed in osteoblasts. The Actn3 -/- mouse displays significantly reduced bone mass, with reduced cortical bone volume (-14%) and trabecular number (-61%) seen by microCT. Dynamic histomorphometry indicated this was due to a reduction in bone formation. In a cohort of postmenopausal Australian women, ACTN3 577XX genotype was associated with lower BMD in an additive genetic model, with the R577X genotype contributing 1.1% of the variance in BMD. Microarray analysis of cultured osteoprogenitors from Actn3 -/- mice showed alterations in expression of several genes regulating bone mass and osteoblast/osteoclast activity, including Enpp1, Opg and Wnt7b. Our studies suggest that ACTN3 likely contributes to the regulation of bone mass through alterations in bone turnover. Given the high frequency of R577X in the general population, the potential role of ACTN3 R577X as a factor influencing variations in BMD in elderly humans warrants further study. © 2011 Elsevier Inc.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph